Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Jonas

Showing results (261-270 of 314) with videos related to

Pageof 32
Sort By:
Urological Research|January 1, 1991
In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2aW de Riese, E Allhoff, C G Stief, et al.
World Journal of Urology|January 1, 1996
The renal paracrine peptide system--possible urologic implications of urodilatinM Meyer, C G Stief, A J Becker, et al.
Der Urologe. Ausg. A|August 17, 2006
[Benign prostate hyperplasia]U Jonas, A I Gabouev, T R W Herrmann, et al.
Der Unfallchirurg|November 7, 1999
[Extracorporeal shock wave therapy for delayed union of long bone fractures - preliminary results of a prospective cohort study]S Beutler, G Regel, H C Pape, et al.
Urology|February 2, 2000
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissueC G Stief, S Uckert, A J Becker, et al.
Cancer Genomics & Proteomics|August 10, 2019
Reduced Expression of the Cell Cycle Regulator p27<sup>Kip1</sup> within the Invasion Front of Renal Cell Carcinomas Proved to be a Significant Marker for Disease-specific SurvivalA S Merseburger, E VON DER Heyde, A Kobierski, et al.
Urologia Internationalis|September 14, 2007
Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic featuresA S Merseburger, J Serth, E von der Heyde, et al.
Oncology Reports|February 12, 1998
The MXI1 tumor suppressor gene is not mutated in primary prostate cancerM A Kuczyk, J Serth, C Bokemeyer, et al.
World Journal of Urology|June 21, 2002
Recent strategies for the use of paclitaxel in the treatment of urological malignanciesC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
Urological Research|February 28, 2001
Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penisA J Becker, S Uckert, D Tsikas, et al.
Pageof 32

Showing results (261-270 of 314) with videos related to

Sort By:
Pageof 32
Urological Research|January 1, 1991
In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2aW de Riese, E Allhoff, C G Stief, et al.
World Journal of Urology|January 1, 1996
The renal paracrine peptide system--possible urologic implications of urodilatinM Meyer, C G Stief, A J Becker, et al.
Der Urologe. Ausg. A|August 17, 2006
[Benign prostate hyperplasia]U Jonas, A I Gabouev, T R W Herrmann, et al.
Der Unfallchirurg|November 7, 1999
[Extracorporeal shock wave therapy for delayed union of long bone fractures - preliminary results of a prospective cohort study]S Beutler, G Regel, H C Pape, et al.
Urology|February 2, 2000
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissueC G Stief, S Uckert, A J Becker, et al.
Cancer Genomics & Proteomics|August 10, 2019
Reduced Expression of the Cell Cycle Regulator p27<sup>Kip1</sup> within the Invasion Front of Renal Cell Carcinomas Proved to be a Significant Marker for Disease-specific SurvivalA S Merseburger, E VON DER Heyde, A Kobierski, et al.
Urologia Internationalis|September 14, 2007
Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic featuresA S Merseburger, J Serth, E von der Heyde, et al.
Oncology Reports|February 12, 1998
The MXI1 tumor suppressor gene is not mutated in primary prostate cancerM A Kuczyk, J Serth, C Bokemeyer, et al.
World Journal of Urology|June 21, 2002
Recent strategies for the use of paclitaxel in the treatment of urological malignanciesC Bokemeyer, J T Hartmann, M A Kuczyk, et al.
Urological Research|February 28, 2001
Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penisA J Becker, S Uckert, D Tsikas, et al.
Pageof 32